Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 25

BeOne Invests $300 Million in U.S. Manufacturing Expansion

Jul 24, 2026
BeOne Medicines has announced a $300 million investment to expand its flagship manufacturing and research facility in Hopewell, New Jersey, strengthening its U.S. production…
Read More...

Kairos and Bayer Partner on Advanced Prostate Cancer Study

Jul 23, 2026
Kairos Pharma has announced a strategic collaboration with Bayer to evaluate a new combination treatment approach for metastatic castration-resistant prostate cancer (mCRPC) that has…
Read More...

Cellares, Papillon Partner to Advance Friedreich’s Ataxia Gene Therapy

Jul 23, 2026
Cellares and Papillon Therapeutics have announced a strategic collaboration to automate the manufacturing of PPL-001, an investigational gene-edited cell therapy being developed to…
Read More...

FDA Approves GSK’s Jideytro for ROS1-Positive Lung Cancer

Jul 23, 2026
GSK has received U.S. Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a next-generation targeted therapy for adults with locally advanced or metastatic…
Read More...

Crystalys Raises $130 Million to Advance Gout Drug Development

Jul 23, 2026
Crystalys Therapeutics has secured $130 million in an oversubscribed Series B financing round to support the late-stage clinical development and commercialization of its lead gout…
Read More...

Evogene, ELEO Partner on Oral PCSK9 Heart Disease Treatments

Jul 23, 2026
Evogene Ltd. and South Korea-based biotechnology company ELEO Inc. have entered into a strategic scientific collaboration to develop next-generation oral small-molecule therapies…
Read More...

Lonza, Engitix Partner to Develop Next-Generation ADC Therapies

Jul 22, 2026
Lonza and Engitix have entered into a licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugates (ADCs), combining Lonza’s established drug…
Read More...

Samsung Biologics Launches $1.46 Billion Bid for PolyPeptide

Jul 22, 2026
Samsung Biologics has announced an agreement to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide Group AG in an all-cash transaction valued at…
Read More...

Halozyme, Incyte Partner on Subcutaneous Blood Cancer Therapy

Jul 22, 2026
Halozyme Therapeutics and Incyte have entered into a global collaboration and licensing agreement to develop additional subcutaneous formulations of Incyte's investigational blood…
Read More...

Bristol Myers Squibb Expands AI Supercomputer for Drug Discovery

Jul 22, 2026
Bristol Myers Squibb (BMS) is significantly expanding its artificial intelligence capabilities with the deployment of a second NVIDIA DGX SuperPOD, strengthening its efforts to…
Read More...
Previous 1 … 23 24 25 26 27 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.